Steele Glenn Jr MD Phd

Steele Glenn Jr MD Phd is listed in filings as Director at PTC Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 6, 2026, including sale activity. Recent filings connect the profile to PTC Therapeutics, Inc. (PTCT). The current snapshot covers public activity from Jan 6, 2026. Reported amounts are shown as $916.2K to $266.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.